Novo Nordisk plans an early January launch for the first daily oral weight-loss pill after receiving FDA approval for a needle-free version of Wegovy.Clinical trials showed that patients taking the 25-milligram semaglutide tablet lost approximately 16.6% of their body weight over 68 weeks.Experts like
Fatima Cody Stanford say the 149 dollar monthly price point increases accessibility following demands from
Donald Trump for lower pharmaceutical costs.
Published: 1h | Updated: 13m